BJJF078
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 564321

CAS#: 2531244-56-9

Description: BJJF078 is a potent inhibitor of recombinant human and mouse Transglutaminase enzyme activity, mainly TG2 and the closely related enzyme TG1.

Chemical Structure

img
BJJF078
CAS# 2531244-56-9
Product data Instruction

Theoretical Analysis

MedKoo Cat#: 564321
Name: BJJF078
CAS#: 2531244-56-9
Chemical Formula: C27H29N3O6S
Exact Mass: 523.18
Molecular Weight: 523.600
Elemental Analysis: C, 61.94; H, 5.58; N, 8.03; O, 18.33; S, 6.12

Price and Availability

Size Price Availability Quantity
5mg USD 90 Ready to ship
10mg USD 150 Ready to ship
25mg USD 250 Ready to ship
50mg USD 450 Ready to ship
100mg USD 750 Ready to ship
200mg USD 1250 Ready to ship
500mg USD 2750 Ready to ship
Bulk inquiry

Synonym: BJJF-078; BJJF 078; BJJF078

IUPAC/Chemical Name: N-(5-((4-Acrylamidopiperidin-1-yl)sulfonyl)naphthalen-1-yl)-3,4-dimethoxybenzamide

InChi Key: IJRQXDUGUAWTNT-UHFFFAOYSA-N

InChi Code: InChI=1S/C27H29N3O6S/c1-4-26(31)28-19-13-15-30(16-14-19)37(33,34)25-10-6-7-20-21(25)8-5-9-22(20)29-27(32)18-11-12-23(35-2)24(17-18)36-3/h4-12,17,19H,1,13-16H2,2-3H3,(H,28,31)(H,29,32)

SMILES Code: O=C(NC1=C2C=CC=C(S(=O)(N3CCC(NC(C=C)=O)CC3)=O)C2=CC=C1)C4=CC=C(OC)C(OC)=C4

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target: BJJF078 effectively inhibits human and mouse transglutaminase activity, particularly TG2 and TG1. BJJF078 does not impact motor symptoms in encephalomyelitis symptoms. In the spinal cord, neither BJJF078 nor ERW1041E induced significant changes in pathology, transglutaminase activity, or inflammation-related marker expression compared to vehicle-treated controls.
In vitro activity: To be determined
In vivo activity: BJJF078 is a potent inhibitor of recombinant human and mouse transglutaminase enzyme activity, mainly TG2 and TG1. BJJF078 did not affect the binding of TG2 to the extracellular matrix substrate fibronectin. ERW1041E (but not BJJF078) resulted in reduced experimental autoimmune encephalomyelitis motor-symptoms. BJJF078 did not cause changes in pathology, transglutaminase activity, or expression of inflammation related markers in the spinal cord. Reference: Erratum in: PLoS One. 2018 Dec 13;13(12):e0209522. https://pubmed.ncbi.nlm.nih.gov/29689097/

Preparing Stock Solutions

The following data is based on the product molecular weight 523.60 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Chrobok NL, Bol JGJM, Jongenelen CA, Brevé JJP, El Alaoui S, Wilhelmus MMM, Drukarch B, van Dam AM. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis. PLoS One. 2018 Apr 24;13(4):e0196433. doi: 10.1371/journal.pone.0196433. Erratum in: PLoS One. 2018 Dec 13;13(12):e0209522. PMID: 29689097; PMCID: PMC5918173.
In vitro protocol: To be determined
In vivo protocol: 1. Chrobok NL, Bol JGJM, Jongenelen CA, Brevé JJP, El Alaoui S, Wilhelmus MMM, Drukarch B, van Dam AM. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis. PLoS One. 2018 Apr 24;13(4):e0196433. doi: 10.1371/journal.pone.0196433. Erratum in: PLoS One. 2018 Dec 13;13(12):e0209522. PMID: 29689097; PMCID: PMC5918173.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Chrobok NL, Bol JGJM, Jongenelen CA, Brevé JJP, El Alaoui S, Wilhelmus MMM, Drukarch B, van Dam AM. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis. PLoS One. 2018 Apr 24;13(4):e0196433. doi: 10.1371/journal.pone.0196433. eCollection 2018. PubMed PMID: 29689097; PubMed Central PMCID: PMC5918173.